| L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults (NCT03761030) | New York State Psychiatric Institute | 2019-01-09 |
| Training Providers to Conduct PRIDES-sSA (NCT03610750) | New York State Psychiatric Institute | 2018-12-01 |
| Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV (NCT03652675) | New York State Psychiatric Institute | 2018-11-01 |
| Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals (NCT03711318) | New York State Psychiatric Institute | 2018-11-01 |
| Improving Accessibility and Personalization of CR for Schizophrenia (NCT03576976) | New York State Psychiatric Institute | 2018-07-16 |
| Web-based Addiction Treatment: Cultural Adaptation With American Indians (NCT03363256) | New York State Psychiatric Institute | 2018-05-30 |
| Treating Hearing Loss to Improve Mood and Cognition in Older Adults (NCT03321006) | New York State Psychiatric Institute | 2018-05-30 |
| Glutamate Reducing Interventions in Schizophrenia (NCT03321617) | New York State Psychiatric Institute | 2018-04-17 |
| Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma (NCT03246113) | New York State Psychiatric Institute | 2018-03-19 |
| A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. (NCT03389750) | New York State Psychiatric Institute | 2018-03-15 |
| Neural and Mobile Assessment OF Behavior Change Among Problem Drinkers (NCT03457077) | New York State Psychiatric Institute | 2018-02-27 |
| Pregabalin as Treatment for Alcohol Use Disorder (NCT03256253) | New York State Psychiatric Institute | 2018-02-15 |
| Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment (NCT03213418) | New York State Psychiatric Institute | 2018-02-01 |
| Computer-Based Treatment for Social Anxiety Disorder (NCT03415022) | New York State Psychiatric Institute | 2018-01-30 |
| Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2) (NCT03369249) | New York State Psychiatric Institute | 2017-12-09 |
| Cognitive Training and Neuroplasticity in Mild Cognitive Impairment (NCT03205709) | New York State Psychiatric Institute | 2017-11-29 |
| Facilitating Rapid Naltrexone Initiation (NCT03345173) | New York State Psychiatric Institute | 2017-11-25 |
| Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD (NCT03476902) | New York State Psychiatric Institute | 2017-10-27 |
| Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders (NCT03344419) | New York State Psychiatric Institute | 2017-10-01 |
| Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy (NCT03317379) | New York State Psychiatric Institute | 2017-10-01 |
| Effects of Marijuana on Symptoms of OCD (NCT03274440) | New York State Psychiatric Institute | 2017-10-01 |
| Safety Planning Intervention to Reduce Short Term Risk (NCT03227991) | New York State Psychiatric Institute | 2017-09-10 |
| Effect of Lorcaserin on Cannabis Withdrawal and Self-administration (NCT03253926) | New York State Psychiatric Institute | 2017-09-05 |
| A Novel Computer-Based Therapy for Social Anxiety (NCT03240003) | New York State Psychiatric Institute | 2017-08-25 |
| The Anti-Inflammatory Effects of Exercise and Peanut Consumption (NCT03212144) | New York State Psychiatric Institute | 2017-08-20 |
| Medication Development for Opioid and Alcohol Abuse (NCT03205423) | New York State Psychiatric Institute | 2017-08-01 |
| A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders (NCT03232346) | New York State Psychiatric Institute | 2017-08-01 |
| Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol (NCT03113409) | New York State Psychiatric Institute | 2017-06-01 |
| Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder (NCT03169816) | New York State Psychiatric Institute | 2017-05-25 |
| Neuroimaging in Patients Undergoing TMS for Depression (NCT02974296) | New York State Psychiatric Institute | 2017-04-30 |
| Pilot Study of the Impact of Exercise on Hippocampal Function (NCT03036371) | New York State Psychiatric Institute | 2017-03-28 |
| Evaluation of Doxazosin to Alter the Abuse of Oxycodone (NCT03415581) | New York State Psychiatric Institute | 2017-02-12 |
| Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients (NCT02913924) | New York State Psychiatric Institute | 2016-12-01 |
| Family Engagement, Cross-System Linkage to Substance Use Treatment for Juvenile Probationers -- Phase 3 (NCT03048552) | New York State Psychiatric Institute | 2016-11-17 |
| Flavanol Augmentation for Antidepressant Non-Responsive Late Life Depression (NCT02943096) | New York State Psychiatric Institute | 2016-11-01 |
| Clinical Trial of AVL-3288 in Schizophrenia Patients (NCT02978599) | New York State Psychiatric Institute | 2016-11-01 |
| Are Bright Lights and Regulated Sleep Effective Treatment for Depression? (NCT03010488) | New York State Psychiatric Institute | 2016-11-01 |
| Pomaglumetad Effects on Glutamate Biomarkers (NCT02919774) | New York State Psychiatric Institute | 2016-10-01 |
| Use of a Mobile Health Sensor in an Open Label Trial of Lorcaserin for the Treatment of Cannabis Use Disorder (NCT02932215) | New York State Psychiatric Institute | 2016-10-01 |
| Promoting Mother-Baby Bonding Through a Relaxation Routine During Pregnancy (NCT02943083) | New York State Psychiatric Institute | 2016-10-01 |
| Facilitating the Behavioral Treatment of Cannabis Use Disorder (NCT02946489) | New York State Psychiatric Institute | 2016-10-01 |
| The Cultural Formulation Interview-Engagement Aid (NCT03044145) | New York State Psychiatric Institute | 2016-09-20 |
| Pharmacogenetics of Naltrexone for Stimulant Abuse (NCT03226223) | New York State Psychiatric Institute | 2016-09-15 |
| Cannabinoid Medication for Adults With OCD (NCT02911324) | New York State Psychiatric Institute | 2016-09-01 |
| A Study of L-DOPA for Depression and Slowing in Older Adults (NCT02744391) | New York State Psychiatric Institute | 2016-08-24 |
| Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder (NCT02803229) | New York State Psychiatric Institute | 2016-07-01 |
| Brief Intervention for OCD Fears (NCT02790710) | New York State Psychiatric Institute | 2016-06-01 |
| Remediation of Auditory Recognition in Schizophrenia With tDCS (NCT02869334) | New York State Psychiatric Institute | 2016-06-01 |
| Brief Intervention to Reduce Fear of Public Speaking (NCT02790736) | New York State Psychiatric Institute | 2016-06-01 |
| Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT) (NCT02645929) | New York State Psychiatric Institute | 2016-04-01 |
| Neural Mechanisms of Disulfiram Effects (NCT02735577) | New York State Psychiatric Institute | 2016-03-01 |
| NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NCT02692157) | New York State Psychiatric Institute | 2016-02-01 |
| Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome (NCT02687165) | New York State Psychiatric Institute | 2016-01-16 |
| Dietary Flavanols and Dentate Gyrus Function (NCT02312310) | New York State Psychiatric Institute | 2015-12-01 |
| Development and Testing of a Smartphone Application to Reduce Substance Use and Sexual Risk Among Homeless Young Adults (NCT02530645) | New York State Psychiatric Institute | 2015-11-01 |
| Nabilone in Cannabis Users With PTSD (NCT03251326) | New York State Psychiatric Institute | 2015-10-01 |
| Medication-Assisted Treatment for Youth With Substance Use Disorders (NCT02593474) | New York State Psychiatric Institute | 2015-09-01 |
| Changing Habits in Anorexia Nervosa: Novel Treatment Development (NCT02382055) | New York State Psychiatric Institute | 2015-09-01 |
| Gabapentin in Patients at Clinical Risk for Psychosis (NCT02557945) | New York State Psychiatric Institute | 2015-08-01 |
| Glutamatergic Modulation of Disordered Alcohol Use (NCT02539511) | New York State Psychiatric Institute | 2015-07-01 |
| Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia (NCT02775864) | New York State Psychiatric Institute | 2015-07-01 |
| Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) (NCT02422290) | New York State Psychiatric Institute | 2015-03-01 |
| Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients. (NCT02255357) | New York State Psychiatric Institute | 2015-03-01 |
| Personalized Computerized Inhibitory Control Training for OCD (NCT02378896) | New York State Psychiatric Institute | 2015-02-01 |
| The Efficacy of a Depression Intervention for Adolescents With Depression and Sleep Disturbances (NCT02429674) | New York State Psychiatric Institute | 2015-02-01 |
| Augmenting Buried in Treasures Workshop (BIT) With In-home Decluttering Practice for Individuals With Hoarding Disorder (NCT02377986) | New York State Psychiatric Institute | 2015-02-01 |
| Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging (NCT02473250) | New York State Psychiatric Institute | 2015-01-01 |
| Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence (NCT02437344) | New York State Psychiatric Institute | 2015-01-01 |
| Biosignatures of Latuda for Bipolar Depression (NCT02239094) | New York State Psychiatric Institute | 2015-01-01 |
| Psychotherapy for Depressed or Anxious Adolescents With Cancer (NCT02232438) | New York State Psychiatric Institute | 2015-01-01 |
| Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial (NCT02373124) | New York State Psychiatric Institute | 2014-12-01 |
| The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving (NCT02316574) | New York State Psychiatric Institute | 2014-12-01 |
| Control and Reward Circuits in Obsessive Compulsive Disorder (NCT02221518) | New York State Psychiatric Institute | 2014-10-01 |
| Overlapping Neural Circuits in Pediatric OCD (NCT02421315) | New York State Psychiatric Institute | 2014-10-01 |
| Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence (NCT02088177) | New York State Psychiatric Institute | 2014-10-01 |
| Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder (NCT02267629) | New York State Psychiatric Institute | 2014-10-01 |
| Treatment Outcome in CBT for Cocaine Use (NCT03538548) | New York State Psychiatric Institute | 2014-09-30 |
| Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone (NCT02294253) | New York State Psychiatric Institute | 2014-09-01 |
| Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD (NCT02206776) | New York State Psychiatric Institute | 2014-09-01 |
| An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD (NCT02259517) | New York State Psychiatric Institute | 2014-09-01 |
| Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep (NCT02189213) | New York State Psychiatric Institute | 2014-07-01 |
| Risks and Benefits of Naloxone Prescribing (NCT02535494) | New York State Psychiatric Institute | 2014-07-01 |
| Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence (NCT01468012) | New York State Psychiatric Institute | 2014-07-01 |
| A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses (NCT04612777) | New York State Psychiatric Institute | 2014-06-15 |
| Treatment of Psychosis and Agitation in Alzheimer's Disease (NCT02129348) | New York State Psychiatric Institute | 2014-06-01 |
| Biomarker Assessment of Glutamatergic Target Engagement (NCT02134951) | New York State Psychiatric Institute | 2014-05-01 |
| Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression (NCT02750631) | New York State Psychiatric Institute | 2014-04-01 |
| Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS (NCT02140775) | New York State Psychiatric Institute | 2014-04-01 |
| Social Circumstances, Parenting Techniques, and Infant Development (NCT02121496) | New York State Psychiatric Institute | 2014-03-01 |
| Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults (NCT01973283) | New York State Psychiatric Institute | 2014-02-19 |
| Mechanisms of Antidepressant Non-Response in Late-Life Depression (NCT01931202) | New York State Psychiatric Institute | 2014-02-19 |
| Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia (NCT02034474) | New York State Psychiatric Institute | 2014-02-01 |
| Imaging Dopamine Release in Depression (NCT02033369) | New York State Psychiatric Institute | 2014-02-01 |
| A Sequenced Behavioral and Medication Intervention for Cocaine Dependence (NCT01986075) | New York State Psychiatric Institute | 2014-01-01 |
| Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP) (NCT02062658) | New York State Psychiatric Institute | 2013-12-01 |
| Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation (NCT02004171) | New York State Psychiatric Institute | 2013-12-01 |
| Vilazodone for Separation Anxiety Disorder (NCT01999920) | New York State Psychiatric Institute | 2013-12-01 |
| Dyadic Therapy for Mothers and Children (NCT02123160) | New York State Psychiatric Institute | 2013-11-01 |
| Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS) (NCT02256085) | New York State Psychiatric Institute | 2013-10-01 |
| Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly (NCT01951118) | New York State Psychiatric Institute | 2013-10-01 |